OK. Maybe not everyone.
But certainly all of pharma! And then much of healthcare – payers, insurance companies, private medicine, even some doctors, although not all.
Notice what’s missing?
Patients! Patients aren’t talking about adherence!
So what is going on here? We all know big pharma is facing a very uncertain future. Lots of big – read profitable – products going off patent, and, of course, the rise in the use of generics, so where to go to continue to grow profits. Of course, everyone is looking to emerging markets, but even there it is becoming clear that the future is not as promising as it once appeared to be, with strong price pressures from governments, massive competition from within big pharma and a market that does not want to be dominated by big international players. So patient adherence is growing in importance.